“Results: When delivered during systemic sensitisation, pravastatin suppressed OVA induced proliferation and production of Th2 type cytokines such as IL5 in spleen cells ex vivo and in vitro.”
“We also found that pravastatin attenuated the antigen presenting capacity of CD11c+ cells obtained from the OVA challenged lung.”